Related Experiment Video
Updated: Aug 6, 2026

Amikacin Protection Assay for Quantification and Visualization of Escherichia coli Cell Invasion
Published on: July 3, 2026
Amikacin-resistant atypical mycobacterial keratitis
Nisha Vilas Rahul1, Himansu Sekhar Behera2, Smruti Rekha Priyadarshini3
1Cornea and Anterior Segment Services, L V Prasad Eye Institute, Bhubaneswar Campus, Bhubaneswar, Odisha, India.
None:
Here, we report a novel case of amikacin-resistant atypical mycobacterial keratitis in a man in his third decade. He presented with gradual diminution of vision associated with pain, redness, watering in his left eye of 1½ months' duration, with a characteristic cracked windshield appearance of corneal ulcer. Smear as well as culture showed the presence of atypical mycobacterial species. Based on clinical and microbiological results, 1% amikacin sulfate eye drops was started. However, the subsequent sensitivity report revealed resistance to amikacin. Following this, other broad-spectrum antibiotics were tested in a microbiology laboratory to find an alternative drug and the organism was found sensitive to gentamicin. The patient responded well to fortified gentamicin eye drops.Gentamicin is not routinely used for the treatment of atypical mycobacterial keratitis. However, in cases resistant to amikacin, other broad-spectrum antibiotics should be tested to determine an alternative and suitable antimicrobial drug.
Related Concept Videos
Atypical Pneumonia
Clinical Significance of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA

